LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care. With most of its products indicated for serious and rare diseases, LFB is a major player in this area. The LFB Group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide and is also among the leading European companies for the development of new-generation proteins and treatments based on biotechnologies. With a sustained investment in research and development, the LFB Group bases its strategy on its international deployment and the design of innovative therapies.
View Top Employees from LFBWebsite | https://www.groupe-lfb.com |
Revenue | $774.8 million |
Employees | 2,232 (1,557 on RocketReach) |
Founded | 1994 |
Address | Lfb Sa 3 Avenue Des Tropiques, Courtaboeuf Cedex, Wallis and Futuna 91 958, FR |
Phone | (508) 370-5100 |
Fax | (508) 872-5176 |
Technologies |
JavaScript,
HTML,
Twitter
+26 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Médicaments dérivés du plasma, Healthcare, Médicaments issus du vivant, Bioproduction |
Web Rank | 3 Million |
Keywords | Rare Disease, Biopharmaceuticals, Plasma |
Competitors | Acino, Belupo Pharmaceuticals & Cosmetics Inc., FUJIFILM Diosynth Biotechnologies, Kedrion Biopharma, London Fire Brigade |
SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies |
Looking for a particular LFB employee's phone or email?
The LFB annual revenue was $774.8 million in 2024.
Bruno De Miribel is the CFO of LFB.
1,557 people are employed at LFB.
LFB is based in Courtaboeuf Cedex, Wallis and Futuna.
The NAICS codes for LFB are [541, 541711, 54, 5417, 54171].
The SIC codes for LFB are [2834, 28, 80, 283].